Submit a project

0 results

News from us and our partners

Tags

Topics

0 results

News
13 May, 2026
Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis
News
11 May, 2026
GenSight Biologics Announces Publication on Matching-Adjusted Indirect Comparison of Leber Hereditary Optic Neuropathy Treatments
News
7 May, 2026
Prometheus Materials Announces Strategic Partnership with Green Stream Algae to Scale Microalgae-Based Low-Carbon Cement
News
6 May, 2026
Hemab Therapeutics closes $347M Nasdaq IPO
News
6 May, 2026
CellCentric raises $220M Series D for inobrodib trials
News
6 May, 2026
Signadori Bio raises €11M seed to advance tumour platform
News
5 May, 2026
NanoPhoria Awarded Second-Place Prize in INNLIFES’ “I Protagonisti Dell’innovazione 2026” Contest
News
5 May, 2026
Arzeda and KENT Specialty Milling Announce Strategic Product Development Collaboration
News
30 April, 2026
Hemab Therapeutics prices IPO at $18 per share
News
23 April, 2026
Mozart Therapeutics Announces Positive Interim Phase 1 Data in Adults with Stage 3 Type I Diabetes
News
16 April, 2026
Freya Biosciences reports positive Phase 1 data for FB301
News
14 April, 2026
In memory of Denis Lucquin, Sofinnova chairman
News
7 April, 2026
Biotalys hits first milestone in Syngenta bioinsecticide deal
News
31 March, 2026
Signadori Bio appoints Dr. Selwyn Ho as CEO
News
25 March, 2026
Bioptimus launches STELA spatial biology atlas
News
23 March, 2026
Abivax reports full year 2025 results